We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

U.S. VASOPRESSIN MARKET ANALYSIS

U.S. Vasopressin Market, by Type (Intravenous Injection, Intramuscular Injection, Subcutaneous Injection, and Others), by Application (Anti-diuretic Hormone Deficiency, Gastrointestinal Bleeding, Vasodilatory Shock, Ventricular Tachycardia, and Fibrillation), and by End User (Hospitals, Dental Clinics, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI4985
Pages :120
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

U.S. Vasopressin Market – Competitive Landscape

Major players operating in the U.S. vasopressin market include Par Pharmaceutical, Pfizer Inc., Eagle Pharmaceuticals, Inc., Astellas Pharma Inc., Cumberland Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Athenex, Inc., Otsuka Holdings Co., Ltd, and Azevan Pharmaceuticals, Inc.